Form 4: Pacific Biosciences Officer Sells Shares to Cover Tax Obligations

Mark Van Oene, Chief Operating Officer of Pacific Biosciences, sold 100,773 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On February 18, 2025, Mark Van Oene, the Chief Operating Officer of Pacific Biosciences, sold 100,773 shares of the company's common stock.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• The shares were sold at a weighted average price of $1.878, with individual sale prices ranging from $1.80 to $2.00 per share.
• Following the transaction, Van Oene still beneficially owns 1,496,681 shares of Pacific Biosciences common stock.

Sentiment

Score: 5

Explanation: This Form 4 filing represents a routine transaction to cover tax obligations. It is neither particularly positive nor negative for the company's outlook.

Industry Context

This is a routine transaction for executives to cover tax obligations related to stock-based compensation. It doesn't necessarily reflect a change in the executive's confidence in the company.

Stakeholder Impact

• The sale of shares by an officer could have a minor impact on shareholder sentiment, but is unlikely to have a significant effect.

Key Dates